Evidence Tier: Preclinical / Phase I Safety — TB-500 is a synthetic fragment of Thymosin Beta-4, a 43-amino acid protein naturally produced by the thymus. It plays key roles in actin regulation, cell migration, and tissue repair.
Overview
TB-500 is the synthetic version of a naturally occurring 43-amino acid peptide present in virtually all human and animal cells. Thymosin Beta-4, the parent protein, was first isolated from the thymus gland and is the most abundant member of the beta-thymosin family. TB-500 is primarily studied for its role in regulating actin, a cell-building protein essential for tissue repair and regeneration.
Mechanism of Action
- Actin Sequestration: TB-500 binds to G-actin monomers, regulating cytoskeletal dynamics critical for cell migration
- Cell Migration: Promotes migration of endothelial cells, keratinocytes, and stem cells to injury sites
- Anti-inflammatory: Downregulates inflammatory cytokines in injured tissue
- Angiogenesis: Promotes new blood vessel formation in damaged tissues
- Hair Follicle Stem Cell Migration: Animal studies show promotion of hair follicle stem cell activation
Key Research Findings
Research from multiple institutions has demonstrated TB-500's effects in animal models:
- Cardiac Repair: Improved cardiac function following induced myocardial infarction in murine models (Bock-Marquette et al., Nature, 2004)
- Wound Healing: Accelerated dermal wound closure in rat models with increased angiogenesis
- Corneal Healing: Phase I/II data for RGN-259 (thymosin beta-4 eye drops) in dry eye disease
- Neurological: Promoted oligodendrocyte differentiation and remyelination in CNS injury models
Regulatory Status
FDA: Category 2 (under review). Scheduled for PCAC evaluation July 23-24, 2026.
WADA: Banned under S0 (Non-Approved Substances).
The "Wolverine Stack"
BPC-157 and TB-500 are frequently studied together in preclinical research due to their complementary mechanisms. BPC-157 primarily promotes angiogenesis via VEGFR2, while TB-500 enhances cell migration via actin modulation. This combination is colloquially known as the "Wolverine Stack" in research circles, though no controlled human studies have evaluated the combination.
References
- Bock-Marquette I, et al. "Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair." Nature. 2004;432(7016):466-472.
- Goldstein AL, et al. "Thymosin beta4: a multi-functional regenerative peptide." Expert Opin Biol Ther. 2012;12(1):37-51.
- PeptideWiki. "FDA Picks 7 Peptides for July 2026 Reclassification Vote." peptidewiki.co
Research Disclaimer
This article is compiled from peer-reviewed research and publicly available scientific literature. It is intended for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health-related decisions.